Effect of antineoplastic agents on non proliferating yeast cells: A possible membrane effect of Doxorubicin

Anticancer Research

Volumn 17, Issue 2 A, 1997, Pages 1079-1082

  Karavokyros, Ioannis ^a   Delitheos, Andreas ^a,b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

Antineoplastic treatment; Doxorubicin; Membranes; Non proliferating cells; Oxygen free radicals; Yeast saccharomyces cerevisiae

Indexed keywords

AMSACRINE; ANTINEOPLASTIC AGENT; CISPLATIN; DNA; DOXORUBICIN; FLUOROURACIL; HYDROXYUREA; MELPHALAN; METHOTREXATE; OXYGEN RADICAL; PHOSPHATIDYLINOSITOL; PROCARBAZINE; SODIUM CHLORIDE; VINBLASTINE; WATER;

ARTICLE; CELL MEMBRANE; CELL SUSPENSION; CONTROLLED STUDY; DNA DAMAGE; DRUG EFFECT; DRUG EFFICACY; MEMBRANE DAMAGE; NONHUMAN; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; SURVIVAL RATE;

ANTIBIOTICS, ANTINEOPLASTIC; CELL MEMBRANE; DOXORUBICIN; SACCHAROMYCES CEREVISIAE;

EID: 0030971193     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. White RJ: Microbiological models as screening tools for anticancer agents : potentials and limitations. Ann Rev Microbiol 36: 415-433, 1982.
2. DiPaolo JA and Rosenfield R: The use of anaerobes and respiratorydeficient yeast mutants as a screening procedure for potential tumor inhibiting agents. Cancer Res 18: 1214-1221, 1958.
3. Gause GF and Laiko AV: Yeast mutants with distorted cell membranes as a detection system for antitumor antibiotics. Antibiot Chemother 23: 21-25, 1978.
4. Delitheos A, Karavokyros I and Tiligada E: Response of Saccharomyces cerevisiae strains to antineoplastic agents. J Appl Bacteriol 79: 379-383, 1995.
5. Hannan MA, Zimmer SG and Hazle J: Mechanisms of cisplatin (cisdiaminodichloroplatinum II) induced cytotoxicity and genotoxicity in yeast. Mutation Res 127: 23-30, 1984.
6. Hannan MA: A comparative study of the cytotoxic and genotoxic effects of cisplatin and its analogue, TNO-6 in yeast. Mutation Res 198: 69-72, 1988.
7. Moore CW: Internucleosomal cleavage and chromosomal degradation by bleomycin and phleomycin in yeast. Cancer Res 48: 6837-6843, 1988.
8. Moore CW: Bleomycin induced DNA-repair by Saccharomyces cerevisiae ATP dependent polydeoxyribonucleotide ligase. J Bacteriol 170: 4991-4994, 1988.
9. Nittis J and Wang JC: DNA topoisomerase-targeting agents can be studied in yeast. Proc Natl Acad Sci USA 85: 7501-7505, 1988.
10. Bjornsti MA, Benedetti P, Viglianti GA and Wang JC: Expression of human DNA topoisomerase I in yeast cells lacking yeast DNA topoisomerase I: Restoration of sensitivity to the antitumor drug camptothecin. Cancer Res 49: 6318-6323, 1989.
11. Abe H, Wada M, Kohno K and Kuwano M: Altered drug sensitivities to anticancer agents in radiation-sensitive DNA repair deficient yeast mutants. Anticancer Res 14: 1807-1810, 1994.
12. Tiligada E, Giannakakou P, Karavokyros I, Delitheos A: Effect of calcium channel blockers on the action of various antitumor agents in the yeast Succharomyces cerevisiae. J Appl Bacteriol, in press.
13. Sigfried JM, Burke TG and Tritton TR: Cellular transport of anthracyclines by passive diffusion. Biochem Pharmacol 34: 593-598, 1985.
14. Bates DA, Fung H and Mackilop WJ: Adriamycin uptake, intracellular binding and cytotoxity in Chinese hamster ovary cells. Cancer Lett 28: 213-221, 1985.
15. Freidberg EC: Deoxyribonucleic acid repair in the yeast Saccharomyces cerevisiae. Microbiol Rev 52: 70-102, 1988.
16. Hixon SC, Ocak A, Thomas JE and Daugerty JP: Resistance to adriamycin cytotoxicity among respiratory deficient mutants in yeast. Antimicrob Agents Chemother 17: 443-449, 1980.
17. Erlichman C: Pharmacology of anticancer drugs. In: Basic Science in Oncology (Tannock IF, Hill RP eds). New York, Mc Graw-Hill Inc, 1993, pp. 317-337.
18. McIntosh EM, Ord RW and Storms RK: Transcriptional regulation of the cell cycle dependent thymidilate synthase gene of Saccharomyces cerevisiae. Mol Cell Biol 8: 4636-4624, 1988.
19. Kule C, Ondrejickova O and Verner K: Doxorubicin, daunorubicin and mitoxantrone cytotoxicity in yeast. Mol Pharmacol 46: 1234-1240, 1994.
20. Eilers M, Endo T and Schatz G: Adriamycin, a drug interacting with acidic phospholipids, blocks import of precursor proteins by isolated yeast mitochondria. J Biol Chem 264: 2945-2950, 1989.
21. Endo T, Eilers M and Schatz G: Binding of a tightly folded artificial mitochondrial precursor protein to the mitochondrial outer membrane involves a lipid-mediated conformational change. J Biol Chem 264: 2951-2956, 1989.
22. Bruce IJ and Wilkie D: Effect of aspirin on mitochondrial mutagens in Saccharomyces cerevisiae. Mol Gen Genet 194: 299-302, 1984.
23. Duarte-Karim M, Ruysshcaert JM and Hilderbrand J: Affinity of adriamycin to phospholipids, a possible explanation for cardiac mitochondrial lesions. Biochem Biophys Res Commun 71: 658-663, 1976.
24. Goormarghtigh E, Chatelain P, Caspers J and Ruysschaert JM: Evidence of a complex between adriamycin derivatives and cardiolipin: possible role in cardiotoxicity. Biochem Pharmacol 29: 3003-3010, 1980.
25. Van der Rest ME, Kamminga A, Nakano A, Anraku Y, Poolman B and Konings WN: The plasma membrane of Saccharomyces cerevisiae: Structure Function Biogenesis. Microbiological Rev 59: 304-322, 1995.
26. Henry S, Atkinson K, Kolat A and Culbertson M: Growth and metabolism of inositol starved cells of Saccharomyces cerevisiae. J Bacteriol 130: 472-484, 1977.
27. Ulaszewski S, Woodward J and Cirillo V: Membrane damage associated with inositoless death in Saccharomyces cerevisiae. J Bacteriol 136: 49-54, 1978.
28. Goormarghtigh E, Huart P, Praet M, Brasseur R and Ruysschaert J-M: Structure of the adriamycin-cardiolipin complex. Role in mitochondrial toxicity. Biophys Chcm 35: 247-257, 1990.
29. Culbertson M and Henry S: Inositol requiring mutans of Saccharomyces cerevisiae. Genetics 80: 23-40, 1975.
30. Jackson M and Sin S: Analysis of inositol starvation in an inositol requiring mutant of CHO-K1. J Cell Biol 87: 293a, 1980.
31. Black SM, Beggs JD, Hayes JD, Bartoszeck A, Muramatsu M, Sakai M and Wolf CR: Expression of human glutathione S-transferases in Saccharomyces cerevisiae confers resistance to the anticancer drugs adriamycin and chlorambucil. Biochcm J 268: 309-315, 1990.
32. Homann PJ, Poole MA, Gaynor PM Ho CT and Carman GM: Effect of growth phase on phospholipid biosynthesis in Saccharomyces cerevisiae. J Bacteriol 169: 533-539, 1987.